Patient retrospective evaluation of change: An appropriate outcome measure for clinical trials?

被引：0
|
作者：
Fischer, D [1 ]
Stewart, AL [1 ]
Bloch, DA [1 ]
Lorig, K [1 ]
Laurent, D [1 ]
Holman, HR [1 ]
机构：
[1] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA
来源：
ARTHRITIS AND RHEUMATISM | 1998年 / 41卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1177
引用
收藏
页码：S229 / S229
页数：1
相关论文
共 50 条
  • [1] Capturing the patient's view of change as a clinical outcome measure
    Fischer, D
    Stewart, AL
    Bloch, DA
    Lorig, K
    Laurent, D
    Holman, H
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (12): : 1157 - 1162
  • [2] SELECTING APPROPRIATE OUTCOME MEASURES FOR ALS CLINICAL TRIALS
    Arjunji, R.
    Glowienka, E.
    Maru, B.
    Wiesner, T.
    Meriggioli, M.
    Dabbous, O.
    VALUE IN HEALTH, 2019, 22 : S739 - S739
  • [3] Organ dysfunction as an outcome measure in clinical trials
    Marshall, JC
    EUROPEAN JOURNAL OF SURGERY, 1999, 163 : 62 - 67
  • [4] Measuring fatigue in multiple sclerosis clinical trials: why patient reported outcome measure choice is not immaterial when measuring change
    Hobart, Jeremy
    King, Tanya
    Sappl, Sonia
    Marais, Ida
    Close, James
    Vo, Pamela
    Andrich, David
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 450 - 451
  • [5] Death as a measure of clinical outcome: appropriate only in the otherwise immortal?
    不详
    CLINICAL MEDICINE, 2002, 2 (04) : 381 - 382
  • [6] Appropriate design and outcome measures in multiple sclerosis clinical trials
    Greenstein, JI
    EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 (05) : 503 - 504
  • [7] The Primary Outcome Measure and Its Importance in Clinical Trials
    Andrade, Chittaranjan
    JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (10) : E1320 - E1323
  • [8] Validating new symptom emergence as a patient-centric outcome measure for PD clinical trials
    Zou, Haotian
    Stebbins, Glenn T.
    Simuni, Tanya
    Luo, Sheng
    Cedarbaum, Jesse M.
    PARKINSONISM & RELATED DISORDERS, 2024, 128
  • [9] Clinical trials in multiple sclerosis - The importance of the outcome measure
    Zajicek, J
    Thompson, A
    Hobart, J
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (08): : 1215 - 1215
  • [10] Use of MRI as an outcome measure in clinical trials in RA
    Annette H. M. van der Helm–van Mil
    Nature Reviews Rheumatology, 2012, 8 : 643 - 644
12345